Given that Wnt activation also contributes towards remodelling and HF development following MI27, and that sFRP2 treatment has produced beneficial outcomes in the infarcted rat heart28, we conducted a study into the effects of PMCA4 inhibition after MI. The gene discussed is SFRP2; the disease is myocardial infarction.